<?xml version="1.0" encoding="UTF-8"?>




<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>POGO - Public Health</title>
    <link>http://pogoarchive.pub30.convio.net</link>
    <description>feed-30723944</description>
    <managingEditor></managingEditor>
    <webMaster>Pam Rutter and Michael Smallberg</webMaster>
    <copyright>2008</copyright>
    <generator>Convio Content Management System Module</generator>
    <language>en-us</language>

  

  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-374620991</guid>
    <title>POGO Letter to Associate Commissioner Warner, FDA, Questioning FDA&apos;s Handling of Conflicts of Interest on FDA Advisory Committees</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/letters/public-health/20121108-pogo-letter-to-warner-fda-conflicts-of-interest.html</link>
    <description>POGO questions if FDA is dealing well with conflicts of interest on FDA advisory committees.</description>
    <pubDate>Fri, 09 Nov 2012 00:00:00 -0600</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-303121815</guid>
    <title>FDA Advisors who Endorsed Contraceptive had Industry Ties</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/alerts/public-health/ph-20110112-fda-advisors-who-endorsed-contraceptive.html</link>
    <description>The Food and Drug Administration (FDA) should disregard a joint advisory committee’s support of a controversial birth control pill because four members of the panel had ties to either the contraceptive maker or the maker of a generic version, the Project On Government Oversight (POGO) said Wednesday in a letter to the FDA.</description>
    <pubDate>Thu, 12 Jan 2012 00:00:00 -0600</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-302981297</guid>
    <title>POGO Letter: FDA Advisors on Yaz and Yasmin Have Industry Ties</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/letters/public-health/ph-fda-20120111-pogo-letter-fda-advisors.html</link>
    <description>Since its creation thirty years ago, the Project On Government Oversight (POGO), a nonprofit, nonpartisan organization, has identified instances of financial conflicts of interest in the federal government and successfully pressed to correct them. We recently learned of industry ties among four members, including the acting chair, of a joint meeting last month of two FDA advisory committees—ties that were not disclosed to the public at the committee meeting.

We are writing to ask that you examine several problems related to this episode. We also ask that you inform us of the FDA’s plans to take corrective action. </description>
    <pubDate>Wed, 11 Jan 2012 00:00:00 -0600</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-260314955</guid>
    <title>NIH&apos;s Plan for Public Disclosure Is Getting Help from Senator Grassley</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/alerts/public-health/ph-iis-20110805.html</link>
    <description>One of the best of our government agencies, the National Institutes of Health (NIH), is getting some well-deserved help from Senator Chuck Grassley (R-IA).
In recent years, Senator Grassley exposed several academic physicians for taking large amounts of money from companies with a direct financial interest in their research, some of it funded by the NIH.</description>
    <pubDate>Fri, 05 Aug 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-258199843</guid>
    <title>POGO Letter Urges FDA Not to Weaken Conflict of Interest Standards at Center for Drug Evaluation and Research</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/letters/public-health/ph-fda-20110803.html</link>
    <description>The Project On Government Oversight is a nonpartisan independent watchdog that champions good government reforms. As such, we take a keen interest in the U.S. Food and Drug Administration (FDA), which receives around $4 billion a year in federal taxpayer dollars to regulate aspects of almost 25 percent of the U.S. economy.</description>
    <pubDate>Wed, 03 Aug 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-258214911</guid>
    <title>POGO Questions FDA Official’s ‘Campaign’ to Loosen Conflict of Interest Rules</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/alerts/public-health/ph-fda-20110803.html</link>
    <description>Statements by a top Food and Drug Administration (FDA) official supporting looser ethics rules for agency advisory boards are inaccurate and undercut the public trust, the Project On Government Oversight (POGO) said today in a letter to FDA Commissioner Margaret Hamburg.</description>
    <pubDate>Wed, 03 Aug 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-253711573</guid>
    <title>POGO Letter to FDA Commissioner Hamburg Concerning the Potentially Dangerous Interaction of the Drugs Seroquel and Methodone</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/letters/public-health/ph-fda-20110719.html</link>
    <description>The Project On Government Oversight is a nonpartisan independent watchdog that champions good government reforms. We take a keen interest in the U.S. Food and Drug Administration (FDA), which receives around $4 billion a year in federal taxpayer dollars to regulate aspects of almost 25 percent of the U.S. economy.

We are concerned about a letter POGO received this spring from Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER) at the FDA.[1] There is a clear disconnect between what Dr. Woodcock told POGO in the letter and what is happening at the FDA.</description>
    <pubDate>Tue, 19 Jul 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-253703319</guid>
    <title>POGO Statement Regarding Potential Dangerous Interaction Between Seroquel and Methadone</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/alerts/public-health/ph-fda-20110719.html</link>
    <description>The Project On Government Oversight just sent a letter about veteran&apos;s safety to FDA Commissioner Margaret Hamburg.  In that letter, we asked Dr. Hamburg, once again, to notify patients and prescribers about the potential dangerous interaction between Seroquel and methadone. </description>
    <pubDate>Tue, 19 Jul 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-251691105</guid>
    <title>Obama Should Remove Top Advisor on Bioethics</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/alerts/public-health/ph-iis-20110712.html</link>
    <description>A top advisor to President Barack Obama on ethical issues in medicine and science should be removed as chairwoman of a presidential commission because of her failure to address ethical lapses on her own campus, the Project On Government Oversight (POGO) said this week in a letter to President Obama.</description>
    <pubDate>Tue, 12 Jul 2011 00:00:00 -0500</pubDate>    
    </item>
  
    <item>
    <guid isPermaLink="false">pogoarchive.pub30.convio.net-251363330</guid>
    <title>POGO Letter to OMB Director Jacob Lew Regarding Proposed NIH Rule on Financial Arrangements between Researchers and Industry</title>
    <link>http://pogoarchive.pub30.convio.net/pogo-files/letters/public-health/ph-iis-20110711-1.html</link>
    <description>An intrusion by the Office of Management and Budget (OMB) may be about to undermine the integrity of medical research supported by the National Institutes of Health (NIH). A new rule proposed by NIH will increase transparency in the financial arrangements of NIH funded researchers in medical schools and universities. However, the Project On Government Oversight (POGO) is concerned that OMB may weaken or block an important part of the proposed new rule.  </description>
    <pubDate>Mon, 11 Jul 2011 00:00:00 -0500</pubDate>    
    </item>
  
  </channel>
</rss>

